Related Experiment Video
Updated: Jul 6, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
[STIGMATIZATION OF PATIENTS WITH SUBSTANCE USE DISORDERS AS A RISK FACTOR IN PSYCHO-NARCOLOGICAL CARE]
T S Kugaevskaya1,1,2
1N. A. Semashko National Research Institute of Public Health 105064 Moscow Russia.
Abstract:
The relevance of the topic is determined by data from numerous studies indicating a significantly higher prevalence of stigma toward individuals using psychoactive substances compared to patients with other mental disorders. Stigma is recognized as a key problem in modern healthcare systems and is defined as a systemic factor shaping the entire ecosystem of narcological care. It frequently affects the professional activities of mid-level medical personnel manifesting at interconnected levels and forming a vicious cycle that deteriorates treatment quality and outcomes while undermining the health of the staff themselves. Stereotypical and negative perceptions of patients with addictions among mid-level medical personnel lead to discriminatory care practices: ignoring pain complaints unfounded suspicions and the use of derogatory language in communication and documentation. It is stigmatizing treatment that inflicts the most severe psychological trauma becoming the primary barrier to seeking help again. Intra-organizational stigma directly contributes to adverse clinical outcomes increased relapses and mortality. Combating stigma must become the cornerstone of professional support and training programs for mid-level medical personnel as well as efforts to improve the overall quality of narcological care.
More Related Videos
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Drug Dependence
CNS Depressants: Alcohol and Nicotine
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

